trending Market Intelligence /marketintelligence/en/news-insights/trending/mxtpbi8vpgstrgrqplmt-g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Intellipharmaceutics noncompliant with another Nasdaq listing rule

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Intellipharmaceutics noncompliant with another Nasdaq listing rule

Intellipharmaceutics International Inc. said it was no longer in compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement for continued listing.

The Canadian pharmaceuticals company has until May 31 to remedy the situation.

Toronto-based Intellipharmaceutics is also in noncompliant with Nasdaq's minimum bid requirement listing rule and has until June 4 to regain compliance with that condition.